Quotes 5-day view Delayed Nasdaq
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Inmune Bio Inc. is a clinical-stage pharmaceutical immunotherapy company. The Company is focused on developing strategies for oncology that focus on re-engineering and harnessing the innate immune system to treat the patientâ€™s cancer. The Companyâ€™s product candidates (INMB) target cells of the innate immune system that include natural killer cells (NK cells) and myeloid derived suppressor cells, (MDSC cells)....
Notations Surperformance© of INmune Bio, Inc.
Trading Rating :
Investor Rating : -
All news about INMUNE BIO, INC.
05/06 INMUNE BIO, INC. : Results of Operations and Financial Condition, Financial Sta..
05/05 INMUNE BIO : Management's Discussion and Analysis of Financial Condition and Re..
05/05 INmune Bio, Inc. Announces First Quarter 2021 Results and Provides Business U..
04/29 INMUNE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
04/28 INmune Bio, Inc. to Report First Quarter 2021 Financial Results and Provide a..
04/27 INMUNE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
04/26 INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neur..
04/21 INMUNE BIO : B. Riley Starts INmune Bio at Buy with $29 PT; Says Breast Cancer,..
04/14 INMUNE BIO, INC. : Termination of a Material Definitive Agreement (form 8-K)
03/29 INMUNE BIO, INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
03/23 INMUNE BIO, INC. : Other Events (form 8-K)
03/22 INMUNE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
03/22 INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presen..
03/16 INMUNE BIO, INC. : Other Events (form 8-K)
03/15 INMUNE BIO : Files Shelf for Up to $250 Million in Securities
News in other languages on INMUNE BIO, INC.
- No features available -
Analyst Recommendations on INMUNE BIO, INC.
Technical analysis trends INMUNE BIO, INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Number of Analysts
Average target price
Last Close Price
Spread / Highest target
Spread / Average Target
Spread / Lowest Target